269 related articles for article (PubMed ID: 15512865)
1. ALS lessons learned from other neurological diseases. Parkinson's disease.
Fahn S
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():26-30. PubMed ID: 15512865
[No Abstract] [Full Text] [Related]
2. Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy.
Olanow CW; Jankovic J
Mov Disord; 2005; 20 Suppl 11():S3-10. PubMed ID: 15822111
[TBL] [Abstract][Full Text] [Related]
3. Treatment challenges in early stage Parkinson's disease.
Tetrud J
Neurol Clin; 2004 Oct; 22(3 Suppl):S19-33. PubMed ID: 15501364
[No Abstract] [Full Text] [Related]
4. [Clinical pharmacology and therapeutic aspects in certain degenerative neurological diseases].
Maloteaux JM
Bull Mem Acad R Med Belg; 1996; 151(10-11):429-32; discussion 432-4. PubMed ID: 9491620
[TBL] [Abstract][Full Text] [Related]
5. Future therapies for Parkinson's disease.
Hauser RA; Lyons KE
Neurol Clin; 2004 Oct; 22(3 Suppl):S149-66. PubMed ID: 15501363
[No Abstract] [Full Text] [Related]
6. Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions.
Schapira AH; Olanow CW
JAMA; 2004 Jan; 291(3):358-64. PubMed ID: 14734599
[TBL] [Abstract][Full Text] [Related]
7. Measuring the effects of therapy in Parkinson disease.
Shults CW; Haas R; Oakes D; Kieburtz K; Plumb S; Shoulson I; Beal MF; Juncos J; Nutt J
JAMA; 2004 May; 291(20):2430-1; author reply 2431. PubMed ID: 15161889
[No Abstract] [Full Text] [Related]
8. After the diagnosis: living with Parkinson's. There's no cure for Parkinson's disease, but new treatments can ease the symptoms and prolong independence.
Harv Womens Health Watch; 2006 Jun; 13(10):2-4. PubMed ID: 16841381
[No Abstract] [Full Text] [Related]
9. [Initial management and adaptation of Parkinson's disease treatment].
Gérard JM
Rev Med Brux; 2008 Sep; 29(4):229-31. PubMed ID: 18949969
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in Parkinson's disease.
Vécsei L
Ideggyogy Sz; 2002 Nov; 55(11-12):406-7. PubMed ID: 12632802
[No Abstract] [Full Text] [Related]
11. Neuroprotective agents in Parkinson's disease: clinical evidence and caveats.
Hälbig TD; Tse W; Olanow CW
Neurol Clin; 2004 Oct; 22(3 Suppl):S1-S17. PubMed ID: 15501359
[No Abstract] [Full Text] [Related]
12. New small molecules for the treatment of Parkinson's disease.
Müller T
Expert Opin Investig Drugs; 2010 Sep; 19(9):1077-86. PubMed ID: 20645881
[TBL] [Abstract][Full Text] [Related]
13. Treatment of early Parkinson's disease. Part 2.
Simuni T; Lyons KE; Pahwa R; Hauser RA; Comella C; Elmer L; Weintraub D
Eur Neurol; 2009; 61(4):206-15. PubMed ID: 19176961
[TBL] [Abstract][Full Text] [Related]
14. Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease.
Schapira AH
Neurology; 2009 Feb; 72(7 Suppl):S44-50. PubMed ID: 19221314
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease.
Clarke CE; Moore AP
Am Fam Physician; 2007 Apr; 75(7):1045-8. PubMed ID: 17427619
[No Abstract] [Full Text] [Related]
16. Parkinson's disease. More than meets the eye.
Imke S
Adv Nurse Pract; 2003 Sep; 11(9):42-4, 47-8, 51 passim. PubMed ID: 14521108
[No Abstract] [Full Text] [Related]
17. ALS lessons learned from other neurological diseases. Neuro-oncology.
Schold SC
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():34-5. PubMed ID: 15512867
[No Abstract] [Full Text] [Related]
18. Treatment of advanced Parkinson's disease.
Diamond A; Jankovic J
Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
[TBL] [Abstract][Full Text] [Related]
19. Bioenergetic approaches for neuroprotection in Parkinson's disease.
Beal MF
Ann Neurol; 2003; 53 Suppl 3():S39-47; discussion S47-8. PubMed ID: 12666097
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic trials in ALS.
Bradley W
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):6-7. PubMed ID: 12745610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
